Navigation Links
Town Health and Ping An Insurance (Group) Company of China, Ltd. Join Forces to Develop and Manage Clinic Chain in Pearl River Delta Area
Date:4/9/2008

d providing 1.3 billion of Chinese with quality healthcare and medical services under the successful business model of Hong Kong. We believe that the join forces will bring all parties to building the number one brand in clinic chains in China."

Dr. Cho Kwai Chee, Chief Executive Officer of Town Health continued, "We are pleased to enter into an exclusive framework agreement with Ping An Trust Co. to establish and manage clinic chain in the Guangdong provinces. A special trust with an initial fund of RMB 300 million will be established, which will be contributed equally for RMB150 million by each of Town Health and a qualified subsidiary of Ping An Group; total fund of Ping An Trust may be increased to RMB500 million if necessary. The fund will be used to implement the clinic chain project with providing medical services to residents in the Pearl River Delta area with high quality and standard services. Ping An Group has a popular reputation in the market, with the renowned brand name, versatile sales experience and massive clientele. Together with the successful management and business model of Town Health, the management is confidence with the combined forces to tap into the mainland China clinic chain industry. The granting of call option to Ping An Group is a vote of confidence in the performance and proven ability to manage clinic chain business by Town Health. We strongly believe the clinic chain project in the Pearl River Delta area will grow vigorously and generate positive results."

Exclusive Agreement to Develop and Manage Chain Clinics in Pearl River Delta Area with Ping An Trust Co.

Pursuant to the framework agreement, Guangdong Town Health (as the agent of the Group) and Ping An Trust Co. are entering into an exclusive agreement to develop and manage chain clinics in Guangdong, in particular the Pearl River Delta area.

The Group (through Guangdong Town Health) and a qualified Ping An subsidiary company shall participate and i
'/>"/>

SOURCE Town Health International Holdings Co. Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Air pollution linked to cardiovascular risk indices in healthy young adults
4. More proof needed of safety and quality of electronic personal health records
5. Health care incentive model offers collaborative approach
6. Loneliness is bad for your health
7. Mailman School of Public Health study examines link between racial discrimination and substance use
8. Green Tea May Brew Up Healthier Skin
9. For Health Info, Women Often Turn to the Web
10. Record Number of Americans Lack Health Insurance
11. U.S. Research Funding Continues to Flatten as U.S. Health Costs Climb - in August 31 Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2008)...TESVILLE, Ind., Dec. 5 T...: HI ) has declared a regular quarterly cash,di... stock, a 1.4 percent,increase over the previous ...,is payable Dec. 31, 2008, to shareholders of reco...lenbrand has paid quarterly dividends since its de...
(Date:12/5/2008)...W YORK, Dec. 5 Empire BlueCross Bl...tted more than $1 million to not-for-profit,organ...n. This amount is the,result of personal giving ...llPoint Foundation, Inc. , "In this difficu...anizations are especially in need of help," said M...
(Date:12/5/2008)...F patients 3 times more likely to suffer heart pro...althDay News) -- People with the deadly lung disea...imes more likely than people without the disease t...ack, according to a British study. , "If you l...y a threefold increased risk of acute coronary syn...
(Date:12/5/2008)...TTLE FALLS, N.J., Dec. 5 ...t income of $3,333,000, or $0.20 per diluted share... first quarter ended October 31, 2008, inclusive o...ur Dutch manufacturing operations to the United St... or $0.12 per diluted share, on sales of $60,005,0...
Breaking Medicine News(10 mins):Health News:Empire BlueCross BlueShield Associates Commit Over $1 Million to Community Organizations in 2008 2Health News:Lung Disease Tied to Increased Risk for Cardiac Events 2Health News:Cantel Medical Reports 72% Increase in Net Income on Record Sales - EPS of $0.20 vs. $0.12 for Quarter Ended October 31, 2008 2Health News:Cantel Medical Reports 72% Increase in Net Income on Record Sales - EPS of $0.20 vs. $0.12 for Quarter Ended October 31, 2008 3Health News:Cantel Medical Reports 72% Increase in Net Income on Record Sales - EPS of $0.20 vs. $0.12 for Quarter Ended October 31, 2008 4Health News:Cantel Medical Reports 72% Increase in Net Income on Record Sales - EPS of $0.20 vs. $0.12 for Quarter Ended October 31, 2008 5Health News:Cantel Medical Reports 72% Increase in Net Income on Record Sales - EPS of $0.20 vs. $0.12 for Quarter Ended October 31, 2008 6
...y hospitals for patients age 18 and older involved...ntal health disorders or substance use related dis...study presents the first documentation of the full...e abuse disorders on U.S. community hospitals. Acc...
...will frame stricter rules for the chemists to// cu...uth. Medical Education and Research Minister Tiks...partment and the pharmacy council would ensure tha...te employed qualified pharmacists to dispense medi...
... given us adequate reasons to make fish a part of ...popular component in fish has always hogged the sp...es conducted by Dutch researchers suggest that Ome...nst age-connected cognitive-decline. During the s...
...ement could make the aggrieved die from a broken h...hat sections in the brain in charge of memory, lea...people who are grieving. They say that important r...a negative loop which could cause heart rhythms to...
Other Medicine News:Health News:One Fourth of Hospital Patients Admitted for Mental Health or Drug Abuse Disorder 2
(Date:12/5/2008)... , , Presentations Will Highlight Researc... , GAITHERSBURG, Md., Dec. 5 /PRNewswire-First...today that the company will present on GenVec,s ma...ropical Medicine and Hygiene (ASTMH) 57th Annual M...n December 7-11, 2008. Two presentations, highligh...
(Date:12/4/2008)..., Calif., Dec. 4 Long-term data pu...ted decrease in Mitral Vale Area (MVA),after repa...regurgitation (MR),is not associated with clinica...th two years of follow-up, none of the patients tr...ry for mitral stenosis. At 12 months no,important...
(Date:12/4/2008)...alif.,Dec. 4 Velos, Inc., the reco...ials management information systems, today announc...rsity of Kansas Medical Center (KU Medical Center...n a comprehensive, system-wide roll-out that suppo...clinical information needs of the institution,s cl...
(Date:12/3/2008)...de treatment alleviates long-term anemia and organ...ations , , MEMPHIS, Tenn., Dec. 3 /PRNewsw...t a corrective gene into mouse blood cells, scient... alleviated sickle cell disease pathology. In thei...mice showed essentially no difference from normal ...
Breaking Medicine Technology:GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting 2GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting 3Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 2Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 3Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 4University of Kansas Medical Center to Deploy Velos eResearch System-Wide 2University of Kansas Medical Center to Deploy Velos eResearch System-Wide 3Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3Nanomedicine research for prostate cancer supported by 245 million gift 2047 1Nanomedicine research for prostate cancer supported by 245 million gift 2047 2Nanomedicine research for prostate cancer supported by 245 million gift 2047 3CSHL scientists make progress in determining how the brain selectively interprets sound 10386 1CSHL scientists make progress in determining how the brain selectively interprets sound 10386 2Log ic Temperature Sensor Receives EN12830 Certification 2826 1Log ic Temperature Sensor Receives EN12830 Certification 2826 2Log ic Temperature Sensor Receives EN12830 Certification 2826 3ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology 10381 1ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology 10381 2ABQAURP Renews Agreement with the National Board of Medical Examiners to Oversee Testing Methodology 10381 3
...07 - Alnylam,Pharmaceuticals, Inc. (Nasdaq: ALNY),...day at the American Association for Cancer,Researc...a,systemically delivered RNAi therapeutic, ALN-VSP...lly other solid tumors as a,new development progra...ed to target vascular endothelial growth factor (V...
... 2007 - Avanir,Pharmaceuticals (NASDAQ:AVNR) today...any,s Phase III clinical trial evaluating the,inve...obromide/quinidine sulfate ("DMQ")), an NMDA antag... pain., The primary endpoint of the trial was base...cale as defined in the Special,Protocol Assessment...
Other Medicine Technology:Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 2Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 3Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 4Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 5Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 2Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 3Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 4Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 5Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 6
Penfield Dissector #2
Leroy scalp clips, sterile, disposable, plastic, infant size, ten clips/package.
Caspar scalp clip system made of plastic with wide lumen box profile and external opening mechanism. It features 4 preselectable opening positions, 15 clips each can be applied in succession, sterile
Raney scalp clips, nickel plate, vial of 12.
Medicine Products: